Simultaneous Quantification of Ketamine and Its Metabolites in Rat Plasma Using LC-MS/MS: Method Development, Validation, and Application

Ketamine (KE) is a clinically important anesthetic and toxicologically relevant compound that undergoes sequential metabolism to norketamine (NKE) and hydroxynorketamine (HNKE).Because parent-only measurements are insufficient to characterize KE disposition, the simultaneous quantification of KE and its metabolites is required.This study aimed to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of KE, NKE, and HNKE in rat plasma.Plasma samples were prepared using a simple protein precipitation procedure, followed by LC-MS/MS analysis in multiple reaction monitoring mode, and the method was successfully applied to rat plasma samples.The validation results demonstrate that the method is selective, sensitive, precise, and accurate, with acceptable linearity within a defined calibration range.The method was successfully applied to rat plasma (n = 5-7) collected 2 h after intraperitoneal KE administration.This method is expected to be useful for the integrated profiling of KE and its metabolites in rat plasma for pharmacokinetic and toxicological studies.

Authors

Institutions

Publication Details

Journal
Drug Targets and Therapeutics
Published
2026-09-28
DOI
https://doi.org/10.58502/dtt.26.0007
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Simultaneous Quantification of Ketamine and Its Metabolites in Rat Plasma Using LC-MS/MS: Method Development, Validation, and Application

Aeri Ha, Sooyeun Lee, Sang-Hoon Song
Drug Targets and Therapeutics
Treatment of Major Depression
article

Simultaneous Quantification of Ketamine and Its Metabolites in Rat Plasma Using LC-MS/MS: Method Development, Validation, and Application

Aeri Ha, Sooyeun Lee, Sang-Hoon Song
article en

Abstract

Ketamine (KE) is a clinically important anesthetic and toxicologically relevant compound that undergoes sequential metabolism to norketamine (NKE) and hydroxynorketamine (HNKE).Because parent-only measurements are insufficient to characterize KE disposition, the simultaneous quantification of KE and its metabolites is required.This study aimed to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of KE, NKE, and HNKE in rat plasma.Plasma samples were prepared using a simple protein precipitation procedure, followed by LC-MS/MS analysis in multiple reaction monitoring mode, and the method was successfully applied to rat plasma samples.The validation results demonstrate that the method is selective, sensitive, precise, and accurate, with acceptable linearity within a defined calibration range.The method was successfully applied to rat plasma (n = 5-7) collected 2 h after intraperitoneal KE administration.This method is expected to be useful for the integrated profiling of KE and its metabolites in rat plasma for pharmacokinetic and toxicological studies.

Drug Targets and TherapeuticsVol. 5(2)
Keimyung University (KR)
Ministry of Education, National Research Foundation of Korea, Korea Customs Service, Korean National Police Agency
Openalex Percentile: Top 13%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Simultaneous Quantification of Ketamine and Its Metabolites in Rat Plasma Using LC-MS/MS: Method Development, Validation, and Application — Aeri Ha, Sooyeun Lee, et al. · Drug Targets and Therapeutics (2026) | TGRS Research Map | TGRS